Related Experiment Video
Updated: Apr 19, 2026

06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
1.0K
Fall predictors in older cancer patients: a multicenter prospective study
Nathalie Vande Walle, Cindy Kenis, Pieter Heeren
1Department of Geriatric Medicine, University Hospitals Leuven, Leuven, Belgium. koen.milisen@med.kuleuven.be.
BMC Geriatrics
|December 17, 2014
Summary
Falls are a significant issue for older cancer patients. Past falls, fatigue, ADL dependency, and living alone predict future fall risk, necessitating geriatric assessment for prevention.
Area of Science:
- Geriatric Medicine
- Oncology
- Public Health
Background:
- Falls are a major cause of morbidity and mortality in the elderly.
- Limited data exists on falls in older cancer patients.
- Identifying fall predictors is crucial for preventive strategies.
Purpose of the Study:
- To assess fall occurrence in older cancer patients post-treatment decision.
- To identify predictors of falls within 2-3 months of cancer treatment decision.
Main Methods:
- Included older patients (≥70 years) with a cancer treatment decision.
- Baseline geriatric screening (G8, Flemish Triage Risk Screening Tool) and assessment.
- Follow-up questionnaires collected data at 2-3 months; univariate and multivariate analyses were performed.
Main Results:
- 17.6% of patients fell within 2-3 months; 51.4% experienced recurrent falls.
- Predictors of falls included: prior fall history (OR=3.926), fatigue (OR=0.380), ADL dependency (OR=0.492), G8 score (OR=0.471), and living alone (OR=1.631).
- Baseline fall history was a significant predictor of future falls.
Conclusions:
- Falls pose a serious risk to older cancer patients.
- Geriatric screening and assessment effectively identify patients at risk of falling.
- Intervention for identified risk factors is essential to prevent fall-related injuries.
More Related Videos
Related Concept Videos
Cancer Survival Analysis
856
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
856
Treatment Resistent Cancers
1.5K
1.5K
Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Kaplan-Meier Approach
770
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
770

